Zurich, 4 December 2015

Dear Mr. Prats Monné,

RE: Allergen products in Europe for diagnosis and treatment

I am writing to you regarding a pressing matter which is of concern to all stakeholders in the allergycommunity. As you may be aware, there are some EU regulations for allergen extracts for diagnosis andtreatment that are being enforced that could ultimately be detrimental to patient care across Europe. As EAACI President, I urge you in the strongest terms possible to help in preventing the diagnosis and treatment of allergic patients in Europe reverting back to a standard from the start of the previous century.

The European Academy of Allergy and Clinical Immunology (EAACI) is a non-profit organisation active in the field of allergic and immunologic diseases such as asthma, rhinitis, eczema, occupational allergy, food and drug allergy, and anaphylaxis. EAACI was founded in 1956 and has become the largest medical association in Europe in the field of allergy and clinical immunology. It includes over 9000 members from 121 countries, as well as 49 National Allergy Societies.

Read the full letter on Allergen products in Europe for diagnosis and treatment.
Last updated 20 February 2017